Ucb S.A. (OP: UCBJF )

152.50 +2.65 (+1.77%)

Streaming Delayed Price Updated: 11:01 AM EDT, Jul 19, 2024 Add to My Watchlist

Price and Volume

Volume	103
Open	152.50
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	149.85
Today's Range	152.50 - 152.50
52wk Range	69.70 - 152.50
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target

January 02, 2024

Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of...

Via Benzinga

Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst

September 28, 2023

Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics.

Via Benzinga

Performance

YTD	+52.50%	+52.50%
1 Month	+1.77%	+1.77%
3 Month	+18.47%	+18.47%
6 Month	+52.50%	+52.50%
1 Year	+69.61%	+69.61%

More News

Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts

August 31, 2023

Via Benzinga

FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults

June 27, 2023

Via Benzinga

Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path

February 14, 2023

Via Benzinga

UCB's Rare Childhood Epilepsy Drug Scores FDA Approval

March 28, 2022

Via Benzinga

Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane

February 08, 2022

Via Benzinga

UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study

January 21, 2022

Via Benzinga

UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights

January 19, 2022

Via Benzinga

UCB Gets EU Approval For Bimekizumab In Psoriasis

August 25, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.